Depression is a widespread condition affecting approximately 7.5 million parents in the US
each year and may be putting at least 15 million children at risk for adverse health …

Importance Untreated depression during pregnancy has been associated with increased
morbidity and mortality for both mother and child and, as such, optimal treatment strategies …

BACKGROUND: As the coronavirus disease pandemic spread across the United States and
protective measures to mitigate its impact were enacted, parents and children experienced …

Context Neonatal abstinence syndrome (NAS) is a postnatal drug withdrawal syndrome
primarily caused by maternal opiate use. No national estimates are available for the …

The Canadian Network for Mood and Anxiety Treatments (CANMAT) published guidelines
for the management of bipolar disorder in 2005, with a 2007 update. This second update, in …

Background The risk of birth defects after antenatal exposure to selective serotonin-reuptake
inhibitors (SSRIs) remains controversial. Methods We assessed associations between first …

Objective: Selective serotonin reuptake inhibitor (SSRI) use during pregnancy incurs a low
absolute risk for major malformations; however, other adverse outcomes have been …

BackgroundConcerns have been expressed about possible adverse effects of the use of
antidepressant medication during pregnancy, including risk for neonatal pathology and the …

OBJECTIVE: This study was undertaken to provide information on the prevalence of use of
antidepressant drugs among pregnant women in the United States. STUDY DESIGN: A …

Adaptation of the brain to the presence of a drug predicts withdrawal on cessation. The
outcome of adaptation is often referred to as 'physical dependence'in pharmacology, as …